News | July 14, 2020
In a recent first-of-its-kind phase IV, Kissability study for an injectable hyaluronic acid (HA) lip filler, subject satisfaction as well as partner satisfaction were evaluated following treatment with Restylane Kysse. Many consumers...
News | July 10, 2020
Azitra, Inc. has been issued a patent for the company’s engineered bacterial strain discovery platform. The United States Patent and Trademark Office (USPTO) has issued US Patent No. 10,702,558, which includes broad composition of...
News | July 9, 2020
The FDA has accepted the Biologics License Application (BLA) for Leo Pharma’s tralokinumab for the treatment of adults with moderate-to-severe atopic dermatitis (AD), the company says. A taget action date has been set in the second...
Acquisitions and Mergers
Business of Medicine
Earnings and Financials
Phase 3/4 Trials
Product Launches and Updates
Research and Publications
Skin of Color
Mount Sinai Researcher Receives NIH Grant to Study Immune Responses of Patients With Inflammatory Skin Diseases in the Setting of COVID-19
Pulse Biosciences, Inc.’s Nano-Pulse Stimulation Technology Produces Favorable Results for Warts and All
Phase 2 Studies: Revance’s DaxibotulinumtoxinA for Injection Looks Good for Forehead Lines, Crow’s Feet